logo

Accurate quantification of neurologic disease over time

Sector: Commercial • Location: Norway

Source: EU Funding & Tenders Portal

Project
Ongoing

A research discovery has little relevance if it never makes an impact on its target users. A key challenge for radiology is that very few diagnostic innovations end up changing clinical practice. Most clinical decision-making processes follow the same hypothesis-driven approach where the association between a biomarker and disease status are assessed by trial-and-error. By forcing the patients’ da

Project Information FAQ

Project Information

4 Q
The project “Accurate quantification of neurologic disease over time” is an infrastructure initiative in the Commercial sector, located in Norway. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Want to explore the full details? View the full report

Participants

Sponsoring Agency

Obfuscated Data

Company

Obfuscated Data

Status

Original status

ongoing

Taiyo status

Obfuscated Data

Taiyo last update

00-00-0000

Available timestamps

00-00-0000

Available timestamp type

Obfuscated Data

Contact

Contact name

Obfuscated Data

Phone

0000000000

Email

ObfuscatedData@email.com

Address

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description

A research discovery has little relevance if it never makes an impact on its target users. A key challenge for radiology is that very few diagnostic innovations end up changing clinical practice. Most clinical decision-making processes follow the same hypothesis-driven approach where the association between a biomarker and disease status are assessed by trial-and-error. By forcing the patients’ data into traditional paradigms, we are inherently making poor use of the available information. Moreover, a new drug or change in treatment have little impact if the intervention is initiated at a late stage. For a patient with short life expectancy, this scenario is unacceptable. A new diagnostic paradigm is needed to catch disease status before it becomes symptomatic. Based on the work of an ERC Starting Grant, we introduce a new paradigm for clinical neuroimaging, coined synthetic biomaps, where artificial intelligence brings to life hidden information stored in diagnostic images. As an intelligent decision-support system, CHRONOS is a fully developed software prototype that enhance classical image analyses with synthetic biomaps to produce smarter and better diagnoses of disease. We showcase how a growing brain tumor change the entire architecture of the brain more than six months before these changes are observed by traditional means. This innovative step will allow the treating physician to make the correct clinical decisions at an unprecedented and early timepoint. We have integrated our invention in a hospital-approved digital framework that allows our clinical experts to validate the technology and demonstrate its clinical value. Our initial market analysis and a favorable search report show that a substantial commercial value can be realized by positioning CHRONOS at the center of a wider strategy of a new company to introduce sibling AI-imaging solutions. Τhis project aims to set the stage for an investor ready spinout company based on the CHRONOS technology.

Original sub-sector

Obfuscated

Original Currency

USD

Original budget

000000000000000

Procurement method

Obfuscated Data

Budget

000000000000000

Location

Region

Obfuscated

Country

Obfuscated

State

Obfuscated Data

County

Obfuscated

Location

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability

High

Data quality score

100%

Source

Obfuscated Data

URL

obfuscated_data,obfuscateddata.com

More Details

Project Type

Obfuscated Data

Article Published Date

Obfuscated Data